Jagged/Notch signalling is required for a subset of TGFΒ1 responses in human kidney epithelial cells

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1803, Issue 12, 2010, Pages 1386-1395

  Nyhan, Kristine C ^a   Faherty, Noel ^a   Murray, Gregg ^a   Cooey, Laurence Berubé ^a   Godson, Catherine ^a   Crean, John K ^a   Brazil, Derek P ^b  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Gamma secretase; Jagged Notch pathway; Kidney epithelial cell; Transforming growth factor beta

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; ALPHA ACTIN; COMPLEMENTARY DNA; CONNECTIVE TISSUE GROWTH FACTOR; CYTOKINE; GAMMA SECRETASE; GAMMA SECRETASE INHIBITOR; JAGGED1; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; NOTCH RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; SMOOTH MUSCLE ACTIN; THROMBOSPONDIN 1; UVOMORULIN; VIMENTIN;

ARTICLE; CELL SHAPE; CELL TYPE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSKELETON; DIABETIC NEPHROPATHY; EPITHELIUM CELL; FIBROSIS; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; KIDNEY CELL; KIDNEY EPITHELIUM; KIDNEY FIBROSIS; KIDNEY PROXIMAL TUBULE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

CALCIUM-BINDING PROTEINS; CELL LINE; EPITHELIAL CELLS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY; MEMBRANE PROTEINS; MICROSCOPY, FLUORESCENCE; POLYMERASE CHAIN REACTION; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 77957790485     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2010.09.001     Document Type: Article

References (48)

1. Border W.A., Ruoslahti E. Transforming growth factor-beta in disease: the dark side of tissue repair. J. Clin. Invest. 1992, 90:1-7.
2. Yamamoto T., Nakamura T., Noble N.A., Ruoslahti E., Border W.A. Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:1814-1818.
3. Miyazono K., ten Dijke P., Heldin C.H. TGF-beta signaling by Smad proteins. Adv. Immunol. 2000, 75:115-157.
4. Bakin A.V., Tomlinson A.K., Bhowmick N.A., Moses H.L., Arteaga C.L. Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J. Biol. Chem. 2000, 275:36803-36810.
5. Kattla J.J., Carew R.M., Heljic M., Godson C., Brazil D.P. Protein kinase B/Akt activity is involved in renal TGF-beta1-driven epithelial-mesenchymal transition in vitro and in vivo. Am. J. Physiol. Renal. Physiol. 2008, 295:F215-F225.
6. Bakin A.V., Rinehart C., Tomlinson A.K., Arteaga C.L. p38 mitogen-activated protein kinase is required for TGFbeta-mediated fibroblastic transdifferentiation and cell migration. J. Cell Sci. 2002, 115:3193-3206.
7. Gingery A., Bradley E.W., Pederson L., Ruan M., Horwood N.J., Oursler M.J. TGF-beta coordinately activates TAK1/MEK/AKT/NFkB and SMAD pathways to promote osteoclast survival. Exp. Cell Res. 2008, 314:2725-2738.
8. Bhowmick N.A., Ghiassi M., Bakin A., Aakre M., Lundquist C.A., Engel M.E., Arteaga C.L., Moses H.L. Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol. Biol. Cell 2001, 12:27-36.
9. Strutz F., Muller G.A., Neilson E.G. Transdifferentiation: a new angle on renal fibrosis. Exp. Nephrol. 1996, 4:267-270.
10. Kalluri R., Neilson E.G. Epithelial-mesenchymal transition and its implications for fibrosis. J. Clin. Invest. 2003, 112:1776-1784.
11. Yang J., Liu Y. Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am. J. Pathol. 2001, 159:1465-1475.
12. Strutz F., Zeisberg M., Ziyadeh F.N., Yang C.Q., Kalluri R., Muller G.A., Neilson E.G. Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation. Kidney Int. 2002, 61:1714-1728.
13. Iwano M. EMT and TGF-beta in renal fibrosis. Front. Biosci. (School Ed.) 2010, 2:229-238.
14. Iwano M., Plieth D., Danoff T.M., Xue C., Okada H., Neilson E.G. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J. Clin. Invest. 2002, 110:341-350.
15. Strutz F., Okada H., Lo C.W., Danoff T., Carone R.L., Tomaszewski J.E., Neilson E.G. Identification and characterization of a fibroblast marker: FSP1. J. Cell Biol. 1995, 130:393-405.
16. Ng Y.Y., Huang T.P., Yang W.C., Chen Z.P., Yang A.H., Mu W., Nikolic-Paterson D.J., Atkins R.C., Lan H.Y. Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats. Kidney Int. 1998, 54:864-876.
17. Humphreys B.D., Lin S.L., Kobayashi A., Hudson T.E., Nowlin B.T., Bonventre J.V., Valerius M.T., McMahon A.P., Duffield J.S. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am. J. Pathol. 2010, 176:85-97.
18. Lathia J.D., Mattson M.P., Cheng A. Notch: from neural development to neurological disorders. J. Neurochem. 2008, 107:1471-1481.
19. Kopan R., Ilagan M.X. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell 2009, 137:216-233.
20. Mumm J.S., Kopan R. Notch signaling: from the outside in. Dev. Biol. 2000, 228:151-165.
21. Sweeney C., Morrow D., Birney Y.A., Coyle S., Hennessy C., Scheller A., Cummins P.M., Walls D., Redmond E.M., Cahill P.A. Notch 1 and 3 receptor signaling modulates vascular smooth muscle cell growth, apoptosis, and migration via a CBF-1/RBP-Jk dependent pathway. FASEB J. 2004, 18:1421-1423.
22. Cheng H.T., Miner J.H., Lin M., Tansey M.G., Roth K., Kopan R. Gamma-secretase activity is dispensable for mesenchyme-to-epithelium transition but required for podocyte and proximal tubule formation in developing mouse kidney. Development 2003, 130:5031-5042.
23. Wang P., Pereira F.A., Beasley D., Zheng H. Presenilins are required for the formation of comma- and S-shaped bodies during nephrogenesis. Development 2003, 130:5019-5029.
24. Zavadil J., Bitzer M., Liang D., Yang Y.C., Massimi A., Kneitz S., Piek E., Bottinger E.P. Genetic programs of epithelial cell plasticity directed by transforming growth factor-beta. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:6686-6691.
25. Morrissey J., Guo G., Moridaira K., Fitzgerald M., McCracken R., Tolley T., Klahr S. Transforming growth factor-beta induces renal epithelial Jagged1 expression in fibrotic disease. J. Am. Soc. Nephrol. 2002, 13:1499-1508.
26. Walsh D.W., Roxburgh S.A., McGettigan P., Berthier C.C., Higgins D.G., Kretzler M., Cohen C.D., Mezzano S., Brazil D.P., Martin F. Co-regulation of Gremlin and Notch signalling in diabetic nephropathy. Biochim. Biophys. Acta 2008, 1782:10-21.
27. Zavadil J., Cermak L., Soto-Nieves N., Bottinger E.P. Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition. EMBO J. 2004, 23:1155-1165.
28. Kobayashi T., Terada Y., Kuwana H., Tanaka H., Okado T., Kuwahara M., Tohda S., Sakano S., Sasaki S. Expression and function of the Delta-1/Notch-2/Hes-1 pathway during experimental acute kidney injury. Kidney Int. 2008, 73:1240-1250.
29. Nijjar S.S., Wallace L., Crosby H.A., Hubscher S.G., Strain A.J. Altered Notch ligand expression in human liver disease: further evidence for a role of the Notch signaling pathway in hepatic neovascularization and biliary ductular defects. Am. J. Pathol. 2002, 160:1695-1703.
30. Murata K., Ota S., Niki T., Goto A., Li C.P., Ruriko U.M., Ishikawa S., Aburatani H., Kuriyama T., Fukayama M. p63 - key molecule in the early phase of epithelial abnormality in idiopathic pulmonary fibrosis. Exp. Mol. Pathol. 2007, 83:367-376.
31. Niranjan T., Bielesz B., Gruenwald A., Ponda M.P., Kopp J.B., Thomas D.B., Susztak K. The Notch pathway in podocytes plays a role in the development of glomerular disease. Nat. Med. 2008, 14:290-298.
32. Waters A.M., Wu M.Y., Onay T., Scutaru J., Liu J., Lobe C.G., Quaggin S.E., Piscione T.D. Ectopic notch activation in developing podocytes causes glomerulosclerosis. J. Am. Soc. Nephrol. 2008, 19:1139-1157.
33. Kretzler M., Allred L. Notch inhibition reverses kidney failure. Nat. Med. 2008, 14:246-247.
34. Dolan V., Murphy M., Sadlier D., Lappin D., Doran P., Godson C., Martin F., O'Meara Y., Schmid H., Henger A., Kretzler M., Droguett A., Mezzano S., Brady H.R. Expression of gremlin, a bone morphogenetic protein antagonist, in human diabetic nephropathy. Am. J. Kidney Dis. 2005, 45:1034-1039.
35. Roxburgh S.A., Kattla J.J., Curran S.P., O'Meara Y.M., Pollock C.A., Goldschmeding R., Godson C., Martin F., Brazil D.P. Allelic depletion of grem1 attenuates diabetic kidney disease. Diabetes 2009, 58:1641-1650.
36. Zhang J., Chen H., Weinmaster G., Hayward S.D. Epstein-Barr virus BamHi-a rightward transcript-encoded RPMS protein interacts with the CBF1-associated corepressor CIR to negatively regulate the activity of EBNA2 and NotchIC. J. Virol. 2001, 75:2946-2956.
37. Jinnin M., Ihn H., Tamaki K. Characterization of SIS3, a novel specific inhibitor of Smad3, and its effect on transforming growth factor-beta1-induced extracellular matrix expression. Mol. Pharmacol. 2006, 69:597-607.
38. Cheng H.T., Kim M., Valerius M.T., Surendran K., Schuster-Gossler K., Gossler A., McMahon A.P., Kopan R. Notch2, but not Notch1, is required for proximal fate acquisition in the mammalian nephron. Development 2007, 134:801-811.
39. Piscione T.D., Wu M.Y., Quaggin S.E. Expression of Hairy/Enhancer of Split genes, Hes1 and Hes5, during murine nephron morphogenesis. Gene Expr. Patterns 2004, 4:707-711.
40. Jeong H.W., Jeon U.S., Koo B.K., Kim W.Y., Im S.K., Shin J., Cho Y., Kim J., Kong Y.Y. Inactivation of Notch signaling in the renal collecting duct causes nephrogenic diabetes insipidus in mice. J. Clin. Invest. 2009, 119:3290-3300.
41. Wang Z., Li Y., Kong D., Banerjee S., Ahmad A., Azmi A.S., Ali S., Abbruzzese J.L., Gallick G.E., Sarkar F.H. Acquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathway. Cancer Res. 2009, 69:2400-2407.
42. Krupa A., Jenkins R., Luo D.D., Lewis A., Phillips A., Fraser D. Loss of MicroRNA-192 promotes fibrogenesis in diabetic nephropathy. J. Am. Soc. Nephrol. 2010, 21:438-447.
43. Brosius F.C. New insights into the mechanisms of fibrosis and sclerosis in diabetic nephropathy. Rev. Endocr. Metab. Disord. 2008, 9:245-254.
44. Palomero T., Sulis M.L., Cortina M., Real P.J., Barnes K., Ciofani M., Caparros E., Buteau J., Brown K., Perkins S.L., Bhagat G., Agarwal A.M., Basso G., Castillo M., Nagase S., Cordon-Cardo C., Parsons R., Zuniga-Pflucker J.C., Dominguez M., Ferrando A.A. Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nat. Med. 2007, 13:1203-1210.
45. Conery A.R., Cao Y., Thompson E.A., Townsend C.M., Ko T.C., Luo K. Akt interacts directly with Smad3 to regulate the sensitivity to TGF-beta induced apoptosis. Nat. Cell Biol. 2004, 6:366-372.
46. Remy I., Montmarquette A., Michnick S.W. PKB/Akt modulates TGF-beta signalling through a direct interaction with Smad3. Nat. Cell Biol. 2004, 6:358-365.
47. Leong K.G., Niessen K., Kulic I., Raouf A., Eaves C., Pollet I., Karsan A. Jagged1-mediated Notch activation induces epithelial-to-mesenchymal transition through Slug-induced repression of E-cadherin. J. Exp. Med. 2007, 204:2935-2948.
48. Saad S., Stanners S.R., Yong R., Tang O., Pollock C.A. Notch mediated epithelial to mesenchymal transformation is associated with increased expression of the Snail transcription factor. Int. J. Biochem. Cell Biol. 2010, 42:1115-1122.